Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Share-based Compensation (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Share-based Compensation for 9 consecutive years, with $4.6 million as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 19.17% year-over-year to $4.6 million; the TTM value through Mar 2026 reached $17.4 million, down 81.23%, while the annual FY2025 figure was $16.7 million, 83.41% down from the prior year.
  • Share-based Compensation hit $4.6 million in Q1 2026 for Select Medical Holdings, up from $4.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $61.3 million in Q4 2024 and bottomed at $3.9 million in Q1 2025.
  • Average Share-based Compensation over 5 years is $12.0 million, with a median of $10.2 million recorded in 2023.
  • Year-over-year, Share-based Compensation surged 418.45% in 2024 and then tumbled 92.62% in 2025.
  • Select Medical Holdings' Share-based Compensation stood at $9.8 million in 2022, then increased by 20.6% to $11.8 million in 2023, then soared by 418.45% to $61.3 million in 2024, then crashed by 92.62% to $4.5 million in 2025, then grew by 2.54% to $4.6 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $4.6 million, $4.5 million, and $4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.